Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 968-974

  Chataigneau, T ^a   Feletou M ^a   Thollon, C ^a   Villeneuve, N ^a   Vilaine, J P ^a   Duhault, J ^a   Vanhoutte, P M ^b  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

(EDHF) endothelium derived hyperpolarizing factor; Anandamide; Cannabinoid; Electrophysiology; Potassium channels

Indexed keywords

ACETYLCHOLINE; ANANDAMIDE; APAMIN; CANNABINOID RECEPTOR; CHARYBDOTOXIN; DEXANABINOL; GLIBENCLAMIDE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; DRUG RECEPTOR; ENZYME INHIBITOR; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CORONARY ARTERY; GUINEA PIG; HYPERPOLARIZATION; MESENTERIC ARTERY; MUSCLE FIBER MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL MEMBRANE POTENTIAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IN VITRO STUDY; MALE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANIMALS; CAROTID ARTERIES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; GUINEA PIGS; INDOMETHACIN; MALE; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SWINE;

EID: 0031594723     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701690     Document Type: Article

References (32)

1. BORNHEIM, L.M., KIM, K.Y., CHEN, B. & CORREIRA, M.A. (1993). The effects of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism. Biochem. Biophys. Res. Commun. 197, 740-746.
2. BORNHEIM, L.M., KIM, K.Y., CHEN, B.L. & CORREIRA, M.A. (1995). Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem. Pharmacol., 50, 677-686.
3. CAMPBELL, W.B., PRATT, P.F., EDGEMONT, W.S. & HILLARD, C.J. (1997). N-Arachidonylethanolamide (AEA) relaxation of bovine coronary arteries is not mediated by the CB1 cannabinoid receptor. J. Vase. Res., 34, 9.
4. CHATAIGNEAU, T., FELETOU, M., DUHAULT, J. & VANHOUTTE, P.M. (1998). Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br. J. Pharmacol. (in press).
5. CHATAIGNEAU, T., THOLLON, C., ILIOU, J-P., VILLENEUVE, N., FELETOU, M., VILAINE, J-P., DUHAULT, J. & VANHOUTTE, P.M. (1997). Cannabinoid CB1 receptors and endothelium hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. J. Vasc. Res., 34, 11.
6. CHEN, G., SUZUKI, H. & WESTON, A.H. (1988). Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol., 95, 1165-1174.
7. CHEN, G., YAMAMOTO, Y., MIWA, K. & SUZUKI, H. (1991). Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am. J. Physiol., 260, H1888-H1892.
8. CORRIU, C., FELETOU, M., CANET, E. & VANHOUTTE, P.M. (1996). Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br. J. Pharmacol., 119, 959-964.
9. DESARNAUD, F., CADAS, H. & PIOMELLI, D. (1995). Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem., 270, 6030-6035.
10. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
11. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686-691.
12. EDWARDS, G. & WESTON, A.M. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597-637.
13. FELETOU, M. & VANHOUTTE, P.M. (1988). Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol., 93, 515-524.
14. FUKAO, M., HATTORI, Y., KANNO, M., SAKUMA, I. & KITABATAKE, A. (1997). Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothnelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br. J. Pharmacol., 120, 439-446.
15. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
16. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endotheliumderived relaxing and contracting factors. FASEB J., 3, 2007-2018.
17. GARLAND, C.J. & MCPHERSON, G.A. (1992). Evidence that nitricoxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol., 105, 429-435.
18. GARLAND, C.J. & PLANE, K. (1996). Relative importance of endothelium-derived hyperpolarizing factor for the relaxation of vascular smooth muscle in different arterial beds. In Endothelium-Derived Hyperpolarizing Factor. ed. Vanhoutte. P.M. pp. 173-179. Reading U.K.: Gordon & Breach Publishing Group.
19. HAMPSON, A.J., HILL, W.A.G., ZANPHILLIPS, M., MAKRIYANNIS, A., LEUNG, E., EGLEN, R.M. BORNHEIM, L.M. (1995). Anandamide hydroxylation by brain lipoxygenase structures and potencies at the cannabinoid receptor. Biochem. Biophys. Acta-Lipids Lipid Metabol., 1259, 173-179.
20. MCCULLOCH, A.I., BOTTRILL, F.E., RANDALL, M.D. & HILEY, C.R. (1997). Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol., 120, 1431-1438.
21. 2 and prostacyclin. Pharmacol. Rev., 30, 293-331.
22. + channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries. J. Physiol., 489, 723-734.
23. PALMER, R.M.J., FERRIDGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327, 524-526.
24. PARKINGTON, H.C., TARE, M., TONTA, M.A. & COLEMAN, H.A. (1993). Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J. Physiol., 465, 459-476.
25. PETERSSON, J., ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1997). Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br. J. Pharmacol., 120, 1344-1350.
26. PLANE, F., HOLLAND, M., WALDRON, G.J., GARLAND. C.J & BOYLE, J.P. (1997). Evidence that anandamide and EDHH act via different mechanisms in the rat isolated mesenteric arteries. Br. J. Pharmacol., 121, 1509-1511.
27. RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL. D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-120.
28. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.-C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptors. FEBS Lett., 350, 240-244.
29. TAYLOR, S.G. & WESTON, A.H (1988). Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci., 9, 272-274.
30. VANHOUTTE, P.M. & FELETOU, M. (1996). Conclusion: Existence of multiple endothelium-derived hyperpolarizing factor(s). In Endothelium-Derived Hyperpolarizing Factor, ed. Vanhoutte, P.M. pp. 303-305. Reading. U.K.: Gordon & Breach Publishing Group.
31. ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1996). Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol., 117, 1600-1606.
32. ZYGMUNT, P.M., HÖGESTÄTT, E.D., WALDECK, K., EDWARDS, G., KIRKUP, A.J. & WESTON, A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol., 122, 1679-1686.